Kailera Therapeutics, Inc. (KLRA)
Market Closed
10 Aug, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
18. 98
+0.32
+1.7149%
$
2.46B Market Cap
- P/E Ratio
- Div Yield
252,671 Volume
- Eps
$ 18.66
Previous Close 
Want to track KLRA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kailera Therapeutics, Inc. (KLRA) Statistics
Valuation metrics
Market Cap 2.46B
Enterprise value 2.27B
Trailing P/E (ttm) -14.81
Forward P/E -
PEG ratio -0.15
Price/Sales (ttm) -
Price/Book (mrq) -6.17
Enterprise Value/Revenue -
Enterprise Value/EBITDA -14.35
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 319.96K
Average volume (90 days) 549.38K
Price summary
52-Week low 16.39
52-Week high 28.23
Beta -
50-Day moving average 19.87
200-Day moving average 21.68
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.22%
Return on equity 0.42%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.26
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.63
Total debt (mrq) -
Total Debt/Equity (mrq) -0.03
Current ratio (mrq) 12.01%
Book value per share (mrq) -3.02
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
